Bristol Myers says AstraZeneca’s Imjudo infringes Yervoy patent
"Bristol Myers characterized AstraZeneca's actions as 'willful, egregious, willful and in reckless disregard for valid patent claims.'" Source: Bristol Myers...
"Bristol Myers characterized AstraZeneca's actions as 'willful, egregious, willful and in reckless disregard for valid patent claims.'" Source: Bristol Myers...
If you attend Innovation Tri-Valley's 9th Annual Innovation Forum, you can't help but be impressed by everything that's going on...
Credit: Marcin Klapczynski/Getty Images Tumor mutation burden (TMB) has become a biomarker used to predict patient response to specific immunotherapies....
CyncHealth, Collective Medical and Innsena are recognized by the Department of Health and Human Services' Racial Equity in Postpartum Care...
Released on January 26, 2023 Malignant mesothelioma is one of several cancers that have a specific genetic alteration known as...
Associate editor Howard S. Hochster, MD, discusses differences in access to health care between urban and rural breast cancer patients...
For free, real-time breaking news sent straight to your inbox, sign up for our breaking news emailsSign up for our...
Focusing on a case involving North Carolina's state employee health insurance plan, Reuters and AP question whether the state can...
WASHINGTON, January 26, 2023 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate has agreed and recommends attorneys at law firm...
It is reported that women make up up to 70% of the global healthcare workforce, making them a key contributor...
This article by Andy Miller and Rebecca Grapevine was first published in Kaiser Health News and republished with permission. Andy...
Healthcare providers, insurers, and legislators all agree: healthcare costs are expensive and reimbursements in Indiana are confusing. Legislators on the...